Position in LLY
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$1,002,723
+$161,134 QoQ
Shares Held
836
-8.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.86%
of 13F equity value
Holder Rank
#3,142
of 4,605 holders
Holding Since
Jun 2022
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Fulcrum Equity Management holds $1,608,456 across 3 Drug Manufacturers - General names. LLY ranks #1 (62.3% of the industry book) .
All Filings in LLY
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,002,723 | 836 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $841,589 | 915 | Shares | Sole | 2026-04-02 | |
| 2025-12-31 | $821,055 | 764 | Shares | Sole | 2026-01-06 | |
| 2025-09-30 | $303,674 | 398 | Shares | Sole | 2026-01-06 | |
| 2025-03-31 | $234,558 | 284 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $254,760 | 330 | Shares | Sole | 2025-03-24 | |
| 2024-09-30 | $497,898 | 562 | Shares | Sole | 2024-11-22 | |
| 2024-06-30 | $366,678 | 405 | Shares | Sole | 2024-07-22 | |
| 2022-12-31 | $205,236 | 561 | Shares | Sole | 2023-07-10 | |
| 2022-06-30 | $251,602 | 776 | Shares | Sole | 2022-07-18 | |
| No filing history on record for this holder in this stock. | ||||||